Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 17 studies | 33% ± 17% | |
GABAergic neuron | 8 studies | 45% ± 23% | |
endothelial cell | 8 studies | 29% ± 12% | |
glutamatergic neuron | 8 studies | 43% ± 24% | |
retinal ganglion cell | 6 studies | 55% ± 17% | |
retinal cone cell | 5 studies | 18% ± 3% | |
type I pneumocyte | 5 studies | 21% ± 2% | |
oligodendrocyte | 5 studies | 27% ± 9% | |
retinal pigment epithelial cell | 4 studies | 54% ± 21% | |
Mueller cell | 4 studies | 17% ± 1% | |
interneuron | 4 studies | 47% ± 15% | |
neuron | 3 studies | 33% ± 11% | |
GABAergic interneuron | 3 studies | 24% ± 3% | |
ependymal cell | 3 studies | 27% ± 14% | |
granule cell | 3 studies | 30% ± 7% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 12 studies | 31% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 7706.55 | 2642 / 2642 | 100% | 26.79 | 703 / 705 |
thymus | 81% | 1282.27 | 527 / 653 | 85% | 7.41 | 514 / 605 |
adrenal gland | 29% | 371.95 | 76 / 258 | 80% | 15.12 | 183 / 230 |
eye | 0% | 0 | 0 / 0 | 100% | 11.51 | 80 / 80 |
skin | 2% | 15.79 | 35 / 1809 | 97% | 16.53 | 457 / 472 |
spleen | 97% | 1236.42 | 233 / 241 | 0% | 0 | 0 / 0 |
lung | 46% | 455.36 | 266 / 578 | 31% | 1.62 | 353 / 1155 |
breast | 2% | 15.03 | 10 / 459 | 57% | 3.48 | 633 / 1118 |
heart | 54% | 500.69 | 463 / 861 | 0% | 0 | 0 / 0 |
ovary | 6% | 56.41 | 11 / 180 | 21% | 0.92 | 92 / 430 |
uterus | 4% | 36.04 | 7 / 170 | 23% | 1.28 | 104 / 459 |
muscle | 22% | 231.86 | 180 / 803 | 0% | 0 | 0 / 0 |
intestine | 10% | 84.53 | 100 / 966 | 10% | 0.36 | 52 / 527 |
lymph node | 0% | 0 | 0 / 0 | 17% | 0.93 | 5 / 29 |
stomach | 0% | 2.02 | 1 / 359 | 16% | 0.69 | 47 / 286 |
esophagus | 5% | 39.01 | 73 / 1445 | 11% | 0.48 | 21 / 183 |
kidney | 3% | 26.12 | 3 / 89 | 13% | 0.60 | 116 / 901 |
pancreas | 0% | 0 | 0 / 328 | 13% | 1.08 | 23 / 178 |
peripheral blood | 9% | 185.33 | 86 / 929 | 0% | 0 | 0 / 0 |
bladder | 0% | 0 | 0 / 21 | 8% | 0.44 | 40 / 504 |
tonsil | 0% | 0 | 0 / 0 | 7% | 0.16 | 3 / 45 |
adipose | 4% | 29.60 | 48 / 1204 | 0% | 0 | 0 / 0 |
prostate | 1% | 5.70 | 2 / 245 | 2% | 0.06 | 10 / 502 |
blood vessel | 1% | 7.20 | 11 / 1335 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 1% | 0.03 | 3 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0046854 | Biological process | phosphatidylinositol phosphate biosynthetic process |
GO_0072659 | Biological process | protein localization to plasma membrane |
GO_0015629 | Cellular component | actin cytoskeleton |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0005515 | Molecular function | protein binding |
Gene name | EFR3B |
Protein name | Protein EFR3 homolog B EFR3 homolog B |
Synonyms | KIAA0953 |
Description | FUNCTION: Component of a complex required to localize phosphatidylinositol 4-kinase (PI4K) to the plasma membrane . The complex acts as a regulator of phosphatidylinositol 4-phosphate (PtdIns(4)P) synthesis (Probable). In the complex, EFR3B probably acts as the membrane-anchoring component . Also involved in responsiveness to G-protein-coupled receptors; it is however unclear whether this role is direct or indirect . . |
Accessions | ENST00000403714.8 [Q9Y2G0-1] ENST00000402191.5 H7BXG9 ENST00000401432.7 [Q9Y2G0-3] ENST00000405108.5 [Q9Y2G0-2] ENST00000264719.5 E7ESK9 Q9Y2G0 |